SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%
新闻
EXAS
--
0.00%
--
Exact Sciences Showcases Continued Progress in Cancer Diagnostics at ASCO 2020
PR Newswire · 2天前
Exact Sciences to participate in June investor conferences
PR Newswire · 5天前
Edited Transcript of EXAS earnings conference call or presentation 6-May-20 9:00pm GMT
Thomson Reuters StreetEvents · 6天前
Tread carefully if you're buying biotech stocks, traders say as group nears all-time highs
As biotechnology stocks surge, traders advice investors to be selective.
CNBC.com · 05/21 11:24
Could Exact Sciences Be a Millionaire-Maker Stock?
MotleyFool.com · 05/17 10:46
Tiziana announces positive data on breast cancer recurrence risk test
Seeking Alpha - Article · 05/14 14:14
Exact Sciences up 6% on bullish Cologuard volume
Exact Sciences (EXAS +5.9%) is up, albeit on modest volume, on the heels of its presentation at the BofA Securities Virtual Healthcare Conference during wh
seekingalpha · 05/13 19:49
UPDATE: Evercore Says Is Cautious On Exact Sciences, Says Math Suggests Last Week's Cologuard Volumes Were Down 40% Year Over Year
Benzinga · 05/13 15:08
Hearing Evercore ISI Out With Correction On Earlier Exact Sciences Call, Says Firm's Analysts Misheard On Webcast 60% Growth Was Week-Over-Week Comparison But Was Actually 60% Increase From Apr. Lows
Benzinga · 05/13 15:08
Hearing Evercore ISI Analyst Highlights Exact Sciences Cologuard Volume During First Week Of May Up 60% From Prior Week
-Bloomberg
Bloomberg · 05/13 14:31
Is Exact Sciences Stock a Buy?
Motley Fool · 05/12 15:23
Should Investors Buy the Dip in EXACT Sciences (EXAS) Stock?
Insider Monkey · 05/11 15:19
Exact Sciences Corporation 2020 Q1 - Results - Earnings Call Presentation
Seeking Alpha - Article · 05/11 14:43
Tiziana announces presentation of StemPrintER data at ASCO
Seeking Alpha - Article · 05/11 11:06
B of A Securities Reiterates Buy on Exact Sciences, Raises Price Target to $94
B of A Securities reiterates Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $88 to $94.
Benzinga · 05/07 16:50
Baird Maintains Outperform on Exact Sciences, Raises Price Target to $92
Baird maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target from $90 to $92.
Benzinga · 05/07 15:55
Exact Sciences' (EXAS) Q1 Earnings Fall Y/Y, Margin Expands
Zacks · 05/07 15:09
10 Biggest Price Target Changes For Thursday
Mizuho lifted the price target for Shopify Inc (NYSE: SHOP) from $350 to $600. Shopify closed at $733.53 on Wednesday.
Benzinga · 05/07 12:16
SVB Leerink Maintains Outperform on Exact Sciences, Lowers Price Target to $90
SVB Leerink analyst Puneet Souda maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and lowers the price target from $100 to $90.
Benzinga · 05/07 11:35
Exact Sciences Corp (EXAS) CEO Kevin Conroy on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/07 02:25